col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


7 Results       Page 1

 [1] 
Springer-Verlag: Pharmaceutical Research
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2024―Sep―18 Population Pharmacokinetics of Casirivimab and Imdevimab in Pediatric and Adult Non-Infected Individuals, Pediatric and Adult Ambulatory or Hospitalized Patients or Household Contacts of Patients Infected with SARS-COV-2 Kuan-Ju Lin, Kenneth C. Turner, Maria Rosario, Lutz O. Harnisch, John D. Davis, A. Thomas DiCioccio
2 [GO] 2022―Sep―26 Preventing SARS-CoV-2 Infection Using Anti-spike Nanobody-IFN-β Conjugated Exosomes Xiabing Lyu, Shota Imai, Tomoyoshi Yamano, Rikinari Hanayama
3 [GO] 2022―Jul―28 Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys Jilei Jia, Zhaojuan Yin, Xiao Zhang, Huimin Li, Dan Meng, Qianqian Liu, Hongfang Wang, Meng Han, Shixiang Suo, Yan Liu, Ping Hu, Chunyun Sun, Jing Li, Liangzhi Xie
4 [GO] 2022―Jul―01 A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens Shobha Upreti, Mukesh Samant
5 [GO] 2020―Oct―06 A Systems Biology Workflow for Drug and Vaccine Repurposing: Identifying Small-Molecule BCG Mimics to Reduce or Prevent COVID-19 Mortality Rima Hajjo, Alexander Tropsha
6 [GO] 2020―Aug―10 Repurposing of Kinase Inhibitors for Treatment of COVID-19 Ellen Weisberg, Alexander Parent, Priscilla L. Yang, Martin Sattler, Qingsong Liu, Qingwang Liu, Jinhua Wang, Chengcheng Meng, Sara J. Buhrlage, Nathanael Gray, James D. Griffin
7 [GO] 2020―May―25 Repurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19 Nancy Baker, Antony J. Williams, Alexander Tropsha, Sean Ekins
 [1] 

7 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec